Table 2.
Correlations among study measures
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||
---|---|---|---|---|---|---|---|---|---|---|
1. Age | - | −.06 | .11 | −.37 | −.27** | −.31** | −.18** | .13 | ||
.02 | ||||||||||
2. Opioid dose † | - | −.12 | .08 | −.05 | −.10 | −.24 | .03 | |||
−.13 | ||||||||||
3. Pain duration | - | .29* | .19 | .18 | .13 | −.24 | .18 | |||
4. Pain intensity (BPI) | - | .71** | .51** | .32** | −.10 | |||||
.07 | ||||||||||
5. Pain interference (BPI) | - | .46** | .39** | −.04 | ||||||
.00 | ||||||||||
6. Catastrophizing (PCS) | - | .41** | −.14 | .15* | ||||||
7. Depressive symptoms (BDI) | - | .01 | .00 | |||||||
8. Conditioned pain modulation | - | |||||||||
−.20** | ||||||||||
9. Temporal summation | - |
Correlation is significant at the .01 level.
Correlation is significant at the .05 level.
Only among opioid users; BPI: Brief Pain Inventory; PCS: Pain Catastrophizing Scale; BDI: Beck Depression Inventory